Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models.

Lin YT, Chern Y, Shen CK, Wen HL, Chang YC, Li H, Cheng TH, Hsieh-Li HM.

PLoS One. 2011;6(8):e22924. doi: 10.1371/journal.pone.0022924. Epub 2011 Aug 5.

2.

Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease.

Sadan O, Shemesh N, Barzilay R, Dadon-Nahum M, Blumenfeld-Katzir T, Assaf Y, Yeshurun M, Djaldetti R, Cohen Y, Melamed E, Offen D.

Exp Neurol. 2012 Apr;234(2):417-27. doi: 10.1016/j.expneurol.2011.12.045. Epub 2012 Jan 20.

PMID:
22285250
3.

Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of Huntington's disease.

Rossignol J, Fink K, Davis K, Clerc S, Crane A, Matchynski J, Lowrance S, Bombard M, Dekorver N, Lescaudron L, Dunbar GL.

Stem Cells. 2014 Feb;32(2):500-9. doi: 10.1002/stem.1508.

4.

Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number.

Rossignol J, Fink KD, Crane AT, Davis KK, Bombard MC, Clerc S, Bavar AM, Lowrance SA, Song C, Witte S, Lescaudron L, Dunbar GL.

Stem Cell Res Ther. 2015 Feb 19;6:9. doi: 10.1186/scrt545.

5.

[Expressions of myogenic markers in skeletal muscle differentiation of human bone marrow mesenchymal stem cells].

Liu TY, Dai H, Lin J, Li M, Xiong F, Feng SW, Zhang YN, Zhang C.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Oct;32(5):516-20. doi: 10.3881/j.issn.1000-503X.2010.05.010. Chinese.

6.

Mesenchymal stem cells overexpressing C-X-C chemokine receptor type 4 improve early liver regeneration of small-for-size liver grafts.

Du Z, Wei C, Yan J, Han B, Zhang M, Peng C, Liu Y.

Liver Transpl. 2013 Feb;19(2):215-25. doi: 10.1002/lt.23577.

7.

Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes.

Rossignol J, Boyer C, Lévèque X, Fink KD, Thinard R, Blanchard F, Dunbar GL, Lescaudron L.

Behav Brain Res. 2011 Mar 1;217(2):369-78. doi: 10.1016/j.bbr.2010.11.006. Epub 2010 Nov 9.

PMID:
21070819
8.

Preconditioning mesenchymal stem cells with the mood stabilizers lithium and valproic acid enhances therapeutic efficacy in a mouse model of Huntington's disease.

Linares GR, Chiu CT, Scheuing L, Leng Y, Liao HM, Maric D, Chuang DM.

Exp Neurol. 2016 Jul;281:81-92. doi: 10.1016/j.expneurol.2016.04.003. Epub 2016 Apr 13.

PMID:
27085395
9.

Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis.

Fink KD, Rossignol J, Crane AT, Davis KK, Bombard MC, Bavar AM, Clerc S, Lowrance SA, Song C, Lescaudron L, Dunbar GL.

Stem Cell Res Ther. 2013 Oct 24;4(5):130. doi: 10.1186/scrt341.

10.

Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease.

Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, Sandstrom MI, Skeel RL, Lescaudron L, Dunbar GL.

Behav Brain Res. 2010 Dec 25;214(2):193-200. doi: 10.1016/j.bbr.2010.05.023. Epub 2010 May 21.

PMID:
20493905
11.

Therapeutic effect of mesenchymal stem cells in rats with intracerebral hemorrhage: reduced apoptosis and enhanced neuroprotection.

Wang SP, Wang ZH, Peng DY, Li SM, Wang H, Wang XH.

Mol Med Rep. 2012 Oct;6(4):848-54. doi: 10.3892/mmr.2012.997. Epub 2012 Jul 20.

PMID:
22825663
12.

Therapeutic potential of human induced pluripotent stem cell-derived mesenchymal stem cells in mice with lethal fulminant hepatic failure.

Moslem M, Valojerdi MR, Pournasr B, Muhammadnejad A, Baharvand H.

Cell Transplant. 2013;22(10):1785-99. doi: 10.3727/096368912X662462. Epub 2013 Feb 5.

PMID:
23394436
13.
14.

Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.

Tattersfield AS, Croon RJ, Liu YW, Kells AP, Faull RL, Connor B.

Neuroscience. 2004;127(2):319-32.

PMID:
15262322
15.

Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice.

Hou Y, Ryu CH, Park KY, Kim SM, Jeong CH, Jeun SS.

Stem Cell Res Ther. 2013 Jul 5;4(4):77. doi: 10.1186/scrt228.

16.

Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.

Zhang Y, Liao S, Yang M, Liang X, Poon MW, Wong CY, Wang J, Zhou Z, Cheong SK, Lee CN, Tse HF, Lian Q.

Cell Transplant. 2012;21(10):2225-39. doi: 10.3727/096368912X653020. Epub 2012 Jul 5.

PMID:
22776744
17.

Bone marrow mesenchymal stem cells can improve the motor function of a Huntington's disease rat model.

Jiang Y, Lv H, Huang S, Tan H, Zhang Y, Li H.

Neurol Res. 2011 Apr;33(3):331-7. doi: 10.1179/016164110X12816242542571.

PMID:
21513650
18.

Human neural stem cell transplants improve motor function in a rat model of Huntington's disease.

McBride JL, Behrstock SP, Chen EY, Jakel RJ, Siegel I, Svendsen CN, Kordower JH.

J Comp Neurol. 2004 Jul 19;475(2):211-9.

PMID:
15211462
19.

Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium.

Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M.

Cardiovasc Res. 2008 Jan;77(1):134-42. Epub 2007 Sep 22.

PMID:
18006467
20.

Microanatomical evidences for potential of mesenchymal stem cells in amelioration of striatal degeneration.

Amin EM, Reza BA, Morteza BR, Maryam MM, Ali M, Zeinab N.

Neurol Res. 2008 Dec;30(10):1086-90. doi: 10.1179/174313208X327955. Epub 2008 Sep 3.

PMID:
18768110

Supplemental Content

Support Center